Your browser doesn't support javascript.
loading
Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis.
Kröger, Janine; Meidtner, Karina; Stefan, Norbert; Guevara, Marcela; Kerrison, Nicola D; Ardanaz, Eva; Aune, Dagfinn; Boeing, Heiner; Dorronsoro, Miren; Dow, Courtney; Fagherazzi, Guy; Franks, Paul W; Freisling, Heinz; Gunter, Marc J; Huerta, José María; Kaaks, Rudolf; Key, Timothy J; Khaw, Kay Tee; Krogh, Vittorio; Kühn, Tilman; Mancini, Francesca Romana; Mattiello, Amalia; Nilsson, Peter M; Olsen, Anja; Overvad, Kim; Palli, Domenico; Quirós, J Ramón; Rolandsson, Olov; Sacerdote, Carlotta; Sala, Núria; Salamanca-Fernández, Elena; Sluijs, Ivonne; Spijkerman, Annemieke M W; Tjonneland, Anne; Tsilidis, Konstantinos K; Tumino, Rosario; van der Schouw, Yvonne T; Forouhi, Nita G; Sharp, Stephen J; Langenberg, Claudia; Riboli, Elio; Schulze, Matthias B; Wareham, Nicholas J.
Afiliación
  • Kröger J; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Meidtner K; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
  • Stefan N; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Guevara M; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
  • Kerrison ND; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
  • Ardanaz E; Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany.
  • Aune D; Institute for Diabetes Research and Metabolic Diseases, Helmholtz Centre München, University of Tübingen, Tübingen, Germany.
  • Boeing H; Navarre Public Health Institute, Pamplona, Spain.
  • Dorronsoro M; Instituto de Investigación Sanitaria de Navarra (Navarra Institute for Health Research), Pamplona, Spain.
  • Dow C; CIBER de Epidemiología y Salud Pública, Madrid, Spain.
  • Fagherazzi G; MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.
  • Franks PW; Navarre Public Health Institute, Pamplona, Spain.
  • Freisling H; Instituto de Investigación Sanitaria de Navarra (Navarra Institute for Health Research), Pamplona, Spain.
  • Gunter MJ; CIBER de Epidemiología y Salud Pública, Madrid, Spain.
  • Huerta JM; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, U.K.
  • Kaaks R; Bjørknes University College, Oslo, Norway.
  • Key TJ; German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Khaw KT; CIBER de Epidemiología y Salud Pública, Madrid, Spain.
  • Krogh V; Public Health Division of Gipuzkoa, San Sebastian, Spain.
  • Kühn T; Instituto BioDonostia, Basque Government, San Sebastian, Spain.
  • Mancini FR; Center for Research in Epidemiology and Population Health, INSERM U1018, Villejuif, France.
  • Mattiello A; Paris-Sud, Paris-Saclay University, Villejuif, France.
  • Nilsson PM; Gustave Roussy Institute, Villejuif, France.
  • Olsen A; Center for Research in Epidemiology and Population Health, INSERM U1018, Villejuif, France.
  • Overvad K; Paris-Sud, Paris-Saclay University, Villejuif, France.
  • Palli D; Gustave Roussy Institute, Villejuif, France.
  • Quirós JR; Lund University, Malmö, Sweden.
  • Rolandsson O; Umeå University, Umeå, Sweden.
  • Sacerdote C; Section of Nutrition and Metabolism, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Sala N; Section of Nutrition and Metabolism, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Salamanca-Fernández E; CIBER de Epidemiología y Salud Pública, Madrid, Spain.
  • Sluijs I; Department of Epidemiology, Murcia Regional Health Council, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca, Murcia, Spain.
  • Spijkerman AMW; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Tjonneland A; University of Oxford, Oxford, U.K.
  • Tsilidis KK; University of Cambridge, Cambridge, U.K.
  • Tumino R; Istituto Nazionale dei Tumori, Fondazione IRCCS, Milan, Italy.
  • van der Schouw YT; German Cancer Research Center, Heidelberg, Germany.
  • Forouhi NG; Center for Research in Epidemiology and Population Health, INSERM U1018, Villejuif, France.
  • Sharp SJ; Paris-Sud, Paris-Saclay University, Villejuif, France.
  • Langenberg C; Gustave Roussy Institute, Villejuif, France.
  • Riboli E; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
  • Schulze MB; Lund University, Malmö, Sweden.
  • Wareham NJ; Danish Cancer Society Research Center, Copenhagen, Denmark.
Diabetes ; 67(6): 1200-1205, 2018 06.
Article en En | MEDLINE | ID: mdl-29523632
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Alfa-2-Glicoproteína-HS Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Diabetes Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Alfa-2-Glicoproteína-HS Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Diabetes Año: 2018 Tipo del documento: Article